Track the Arcadia Biosciences, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €1.4m. The latest transaction was reported on 5 February 2025 (Acquisition). Among the most active insiders: Schaefer Thomas J.. Every trade is free.
13
Insider Decl.
n/a
Thresholds
€30,289
9 ops.
Buy Volume
n/a
3 ops.
Sell Volume
44Σ signal
Buys €30,289n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 28,517 of 29,064 companies
9.5
score / 100
Value
0
Quality
19
FCF yld·
Earn yld-172%
EV/EBITDA·
ROE-158%
Gross mgn36%
Net mgn-48%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Arcadia Biosciences, Inc. es una empresa de biotecnología centrada en la mejora de cultivos para una agricultura sostenible. Desarrolla soluciones innovadoras para mejorar la productividad y la calidad de las plantas.